Sex: M
Vaccine: COVID19
Symptoms: Decreased activity, Fatigue, Feeling abnormal, Lethargy, Malaise
Clinical narrative: his father felt bad for a couple days; Didn't feel well; Similar type of reaction as far as lethargy and fatigue following the first three Covid-19 vaccines.; Similar type of reaction as far as lethargy and fatigue following the first three Covid-19 vaccines.; Father laid around a little more and was less active; This is a spontaneous report received from contactable reporter (Consumer (patient's son)).  An elderly male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (ongoing), notes: Diabetes Diagnosed for possibly 5-10 years.; "Congestive heart failure", start date: Feb2021 (ongoing), notes: CHF; "triple by pass" (unspecified if ongoing), notes: Triple by pass In 1998 or 1999; "cardiac stents" (unspecified if ongoing), notes: Cardiac stent Within the last 20 years; "TIA'S" (unspecified if ongoing), notes: had multiple TIA's in the past that have worn away at his cognitive ability; "Pacemaker" (unspecified if ongoing), notes: installed 1.5-2 years ago; "Pain" (unspecified if ongoing); "Bowel regularity" (unspecified if ongoing); "Father contracted Covid-19 prior to receiving any vaccines" (unspecified if ongoing); "worn away at his cognitive ability" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: prior to receiving any vaccines; was hospitalized and previously in rehab from that Covid infection. Concomitant medication(s) included: TAMSULOSIN; OMEPRAZOLE; METFORMIN; FUROSEMIDE; METHYL SALICYLATE; FERROUS SULFATE; BISOPROLOL oral; METAMUCIL [PSYLLIUM HYDROPHILIC MUCILLOID] taken for constipation; POTASSIUM CHLORIDE; LOSARTAN; ACETAMINOPHEN taken for pain; ATORVASTATIN; NITROGLYCERIN; ASPIRIN [ACETYLSALICYLIC ACID]. Vaccination history included: BNT162b2 (DOSE 1), administration date: 04Aug2022, for COVID-19 immunization, reaction(s): "Similar type of reaction as far as lethargy and fatigue"; BNT162b2 (DOSE 1), administration date: 04Aug2022, for Covid-19 Immunization, reaction: "Similar type of reaction as far as lethargy and fatigue"; Bnt162b2 (DOSE 1), for COVID-19 immunization, reaction: "his father felt bad for a couple days"; Bnt162b2 (DOSE 1), for Covid-19 Immunization, reaction(s): "Father laid around a little more and was less active", "Didn't feel well". The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "his father felt bad for a couple days"; MALAISE (non-serious), outcome "unknown", described as "Didn't feel well"; LETHARGY (non-serious), FATIGUE (non-serious), outcome "unknown" and all described as "Similar type of reaction as far as lethargy and fatigue following the first three Covid-19 vaccines"; DECREASED ACTIVITY (non-serious), outcome "unknown", described as "Father laid around a little more and was less active". Additional information: For concomitant medication nitroglycerin, it was reported that the patient had a pacemaker installed 1.5-2 years ago and the patient rarely takes nitroglycerin anymore. Possibly over a year since he's taken it.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201051311 Same patient, different dose/events;US-PFIZER INC-202201051463 Same patient/events, different dose;